Loss of USP28 drives resistance to BRAF targeted therapy in melanoma
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2017-09, Vol.28, p.v442-v442 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v442 |
|---|---|
| container_issue | |
| container_start_page | v442 |
| container_title | Annals of oncology |
| container_volume | 28 |
| creator | Saei, A. Palafox, M. Benoukraf, T. Kumari, N. Jaynes, P.W. Iyengar, P.V. Charles Richard, J.L. Isa, Z.F. Pang, B. Guzman, M. Yang, H. Tam, W.L. Serra, V. Eichhorn, P.J.A. |
| description | |
| doi_str_mv | 10.1093/annonc/mdx377.032 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx377_032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753420385082</els_id><sourcerecordid>S0923753420385082</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1372-f2fa6f30edf022f57e28bb3c828ced3d2c3092c94cdf1bde0d918032795191173</originalsourceid><addsrcrecordid>eNp9kM1OwzAQBi0EEqXwANz8Amn9k8SxOJVCASkSCOjZcuw1GDVxZUcVfXuMwpnTnmY13yB0TcmCEsmXehjCYJa9_eZCLAhnJ2hGq1oWDSnpKZoRyXghKl6eo4uUvgghtWRyhu7akBIODm_fXliDbfQHSDhC8mnUgwE8Bnz7utrgUccPGMHi8ROi3h-xH3APOz2EXl-iM6d3Ca7-7hxtN_fv68eifX54Wq_awlAuWOGY07XjBKwjjLlKAGu6jpuGNQYst8zwrGlkaayjnQViJW3yFCErKikVfI7o9NfEbB3BqX30vY5HRYn6zaCmDGrKoDKbmZuJgSx28BBVMh7yMusjmFHZ4P-hfwCFsmc-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Loss of USP28 drives resistance to BRAF targeted therapy in melanoma</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Saei, A. ; Palafox, M. ; Benoukraf, T. ; Kumari, N. ; Jaynes, P.W. ; Iyengar, P.V. ; Charles Richard, J.L. ; Isa, Z.F. ; Pang, B. ; Guzman, M. ; Yang, H. ; Tam, W.L. ; Serra, V. ; Eichhorn, P.J.A.</creator><creatorcontrib>Saei, A. ; Palafox, M. ; Benoukraf, T. ; Kumari, N. ; Jaynes, P.W. ; Iyengar, P.V. ; Charles Richard, J.L. ; Isa, Z.F. ; Pang, B. ; Guzman, M. ; Yang, H. ; Tam, W.L. ; Serra, V. ; Eichhorn, P.J.A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx377.032</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-09, Vol.28, p.v442-v442</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Saei, A.</creatorcontrib><creatorcontrib>Palafox, M.</creatorcontrib><creatorcontrib>Benoukraf, T.</creatorcontrib><creatorcontrib>Kumari, N.</creatorcontrib><creatorcontrib>Jaynes, P.W.</creatorcontrib><creatorcontrib>Iyengar, P.V.</creatorcontrib><creatorcontrib>Charles Richard, J.L.</creatorcontrib><creatorcontrib>Isa, Z.F.</creatorcontrib><creatorcontrib>Pang, B.</creatorcontrib><creatorcontrib>Guzman, M.</creatorcontrib><creatorcontrib>Yang, H.</creatorcontrib><creatorcontrib>Tam, W.L.</creatorcontrib><creatorcontrib>Serra, V.</creatorcontrib><creatorcontrib>Eichhorn, P.J.A.</creatorcontrib><title>Loss of USP28 drives resistance to BRAF targeted therapy in melanoma</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQBi0EEqXwANz8Amn9k8SxOJVCASkSCOjZcuw1GDVxZUcVfXuMwpnTnmY13yB0TcmCEsmXehjCYJa9_eZCLAhnJ2hGq1oWDSnpKZoRyXghKl6eo4uUvgghtWRyhu7akBIODm_fXliDbfQHSDhC8mnUgwE8Bnz7utrgUccPGMHi8ROi3h-xH3APOz2EXl-iM6d3Ca7-7hxtN_fv68eifX54Wq_awlAuWOGY07XjBKwjjLlKAGu6jpuGNQYst8zwrGlkaayjnQViJW3yFCErKikVfI7o9NfEbB3BqX30vY5HRYn6zaCmDGrKoDKbmZuJgSx28BBVMh7yMusjmFHZ4P-hfwCFsmc-</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Saei, A.</creator><creator>Palafox, M.</creator><creator>Benoukraf, T.</creator><creator>Kumari, N.</creator><creator>Jaynes, P.W.</creator><creator>Iyengar, P.V.</creator><creator>Charles Richard, J.L.</creator><creator>Isa, Z.F.</creator><creator>Pang, B.</creator><creator>Guzman, M.</creator><creator>Yang, H.</creator><creator>Tam, W.L.</creator><creator>Serra, V.</creator><creator>Eichhorn, P.J.A.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Loss of USP28 drives resistance to BRAF targeted therapy in melanoma</title><author>Saei, A. ; Palafox, M. ; Benoukraf, T. ; Kumari, N. ; Jaynes, P.W. ; Iyengar, P.V. ; Charles Richard, J.L. ; Isa, Z.F. ; Pang, B. ; Guzman, M. ; Yang, H. ; Tam, W.L. ; Serra, V. ; Eichhorn, P.J.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1372-f2fa6f30edf022f57e28bb3c828ced3d2c3092c94cdf1bde0d918032795191173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saei, A.</creatorcontrib><creatorcontrib>Palafox, M.</creatorcontrib><creatorcontrib>Benoukraf, T.</creatorcontrib><creatorcontrib>Kumari, N.</creatorcontrib><creatorcontrib>Jaynes, P.W.</creatorcontrib><creatorcontrib>Iyengar, P.V.</creatorcontrib><creatorcontrib>Charles Richard, J.L.</creatorcontrib><creatorcontrib>Isa, Z.F.</creatorcontrib><creatorcontrib>Pang, B.</creatorcontrib><creatorcontrib>Guzman, M.</creatorcontrib><creatorcontrib>Yang, H.</creatorcontrib><creatorcontrib>Tam, W.L.</creatorcontrib><creatorcontrib>Serra, V.</creatorcontrib><creatorcontrib>Eichhorn, P.J.A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saei, A.</au><au>Palafox, M.</au><au>Benoukraf, T.</au><au>Kumari, N.</au><au>Jaynes, P.W.</au><au>Iyengar, P.V.</au><au>Charles Richard, J.L.</au><au>Isa, Z.F.</au><au>Pang, B.</au><au>Guzman, M.</au><au>Yang, H.</au><au>Tam, W.L.</au><au>Serra, V.</au><au>Eichhorn, P.J.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of USP28 drives resistance to BRAF targeted therapy in melanoma</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v442</spage><epage>v442</epage><pages>v442-v442</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdx377.032</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2017-09, Vol.28, p.v442-v442 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdx377_032 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Loss of USP28 drives resistance to BRAF targeted therapy in melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T15%3A28%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20USP28%20drives%20resistance%20to%20BRAF%20targeted%20therapy%20in%20melanoma&rft.jtitle=Annals%20of%20oncology&rft.au=Saei,%20A.&rft.date=2017-09&rft.volume=28&rft.spage=v442&rft.epage=v442&rft.pages=v442-v442&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx377.032&rft_dat=%3Celsevier_cross%3ES0923753420385082%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753420385082&rfr_iscdi=true |